The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for S Williams


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics.EBI
University of Arkansas For Medical Sciences
Quantitative structure-activity relationships (QSARs) of N-terminus fragments of NK1 tachykinin antagonists: a comparison of classical QSARs and three-dimensional QSARs from similarity matrices.EBI
Cambridge University Forvie Site
 
PD 165929 the first high affinity non-peptide neuromedin-B (NMB) receptor selective antagonistEBI
TBA
Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.EBI
Institute For Medical Research
Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT).EBI
Novartis Institutes For Biomedical Research
Novel inhibitors of plasminogen activator inhibitor-1: development of new templates from diketopiperazines.EBI
Xenova
Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor.EBI
Glaxosmithkline
Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase.EBI
Glaxosmithkline
Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors.EBI
Merck
ALPHA-2A ADRENERGIC RECEPTOR MODULATORS AND USES THEREOFBDB
University Of California
Compounds and methods for treating oxalate-related diseasesBDB
Oxalurx
Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofBDB
Enanta Pharmaceuticals
Carbazole-containing amides, carbamates, and ureas as cryptochrome modulatorsBDB
Synchronicity Pharma
Somatostatin receptor subtype 4 (SSTR4) agonistsBDB
Centrexion Therapeutics
TYK2 inhibitors, uses, and methods for production thereofBDB
Nimbus Lakshmi
2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitorsBDB
Centaurus Biopharma
Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereofBDB
Sunshine Lake Pharma
Dihydropyrimidine based hydrazine dihydrochloride derivatives as potent urease inhibitors.BDB
University of Karachi
Inhibition of guinea pig aldehyde oxidase activity by different flavonoid compounds: An in vitro study.BDB
Kermanshah University of Medical Sciences
Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancerBDB
Queen'S University At Kingston
Synthesis and biological evaluation of some new N(4)-substituted isatin-3-thiosemicarbazones.BDB
Bahauddin Zakariya University